Subscribe To
JANX / Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Tops Revenue Estimates
JANX News
By Zacks Investment Research
July 20, 2023
All You Need to Know About Janux Therapeutics, Inc. (JANX) Rating Upgrade to Buy
Janux Therapeutics, Inc. (JANX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This m more_horizontal
By Zacks Investment Research
July 20, 2023
Wall Street Analysts Believe Janux Therapeutics, Inc. (JANX) Could Rally 120.65%: Here's is How to Trade
The consensus price target hints at a 120.7% upside potential for Janux Therapeutics, Inc. (JANX). While empirical research shows that this sought-aft more_horizontal
By Zacks Investment Research
May 9, 2023
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Tops Revenue Estimates
Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compare more_horizontal
By Zacks Investment Research
February 14, 2023
Janux Therapeutics, Inc. (JANX) Surges 5.9%: Is This an Indication of Further Gains?
Janux Therapeutics, Inc. (JANX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate re more_horizontal
By Business Wire
March 1, 2022
Janux Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunoth more_horizontal
By Business Wire
March 1, 2022
Janux Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunoth more_horizontal
By Business Wire
March 1, 2022
Janux Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunoth more_horizontal